Endpoints News reposted this
In today's Endpoints News Health Tech newsletter: - Hims is doubling down on GLP-1 copycats and buying a 503b compounding pharmacy, Ngai Yeung reports. - I spend some time wondering what'll happen when Novo and Lilly's supply is sufficient, and compounding isn't about filling a gap, but about directly competing. - We scooped Devoted Health's $112M raise + plans to expand to 7 new states next year. - Andrew Dunn covers the latest wrinkle in 23andMe CEO Anne Wojcicki's plan to take the genetic testing company private. + more! Read it here, and subscribe! https://lnkd.in/eKkWMGuw https://lnkd.in/eR8UBsji
